Results 121 to 130 of about 1,219,258 (290)
Editorial: Integration and optimization in the chemical process industry
Daniel Florez-Orrego +3 more
doaj +1 more source
Integration of Genetic and Process Engineering for Optimized Rhamnolipid Production Using Pseudomonas putida. [PDF]
Tiso T +15 more
europepmc +1 more source
Foreword Innovative Green Engineering Solutions that Increase Technological Processes Efficiency
Liviu Moldovan
openalex +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Molecule Sensitive Optical Imaging and Monitoring Techniques-A Review of Applications in Micro-Process Engineering. [PDF]
Nachtmann M, Deuerling J, Rädle M.
europepmc +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Using Python to Analyze and Model Chemical Engineering Processes: A Case Study of MSS Drying
Erik Mihelič +3 more
openalex +2 more sources
The Application of Adaptive Analytic Hierarchy Process Driven by Multisource Big Data in the Training of School-Enterprise Joint Engineering Ability [PDF]
Liqing Zhang
openalex +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source

